GLP-1s, Compliance & Clinical Strategy: Expert Advice for 2026 Success with David Caddell
Автор: The Wellness Practice Playbook
Загружено: 2025-12-15
Просмотров: 828
GLP-1s are driving explosive growth in cash-pay clinics - but they’re also creating serious legal exposure for the unprepared.
In this episode, Alex Sidorenkov sits down with David Caddell, President of EC3Health, to unpack the compliance must-knows every clinic needs before promoting semaglutide or tirzepatide.
✅ What’s legal, what’s risky, and how to choose a compounding pharmacy
✅ How to structure your GLP-1 offering for long-term revenue
✅ Why HRT and peptide therapy should follow GLP-1s in the patient journey
If you’re selling semaglutide or tirzepatide or planning to - don’t miss this. It could protect your business and position you for long-term growth.
Доступные форматы для скачивания:
Скачать видео mp4
-
Информация по загрузке: